Back to Trades
Total Value
$62.4K
Filing Date
Apr 1, 2026
1 transaction
Trade Summary
On Mar 27, 2026, Carter Robert Ross, Chief Financial Officer, reported $62.4K of Oncology Institute, Inc. (TOI) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $3.07. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Oncology Institute, Inc.
- Ticker Symbol
- TOI
- CIK
- 0001799191
Insider Information
- Role
- Chief Financial Officer
- Location
- CERRITOS, CA
Filing Details
- Filing Date
- Apr 1, 2026
- Transaction Date
- Mar 27, 2026
- Accession Number
- 0001079973-26-000440
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | Common Stock | 202,914 | — | Grant/Award | — |
| Mar 27, 2026 | Common Stock | 20,320 | $3.07 | Other | $62.4K |
Want live alerts when Carter Robert Ross trades again?
Download Insider Trades to track TOI, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
- (F2)The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026